AYCARDI-FONSECA ERNESTO 4
4 · Xenon Pharmaceuticals Inc. · Filed Sep 18, 2019
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-09-16+65,000→ 65,000 totalExercise: $9.44Exp: 2029-09-15→ Common Shares (65,000 underlying)
Footnotes (1)
- [F1]Vesting over 36 months, in equal amounts, on the last day of each month.